- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03166228
Hemodynamic Changes During Operative Hysteroscopy
Hematological, Biochemical and Hemodynamic Changes During Operative Hysteroscopy Using Consecutive Distension Media
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Operative hysteroscopy has become a standard surgical treatment for abnormal uterine bleeding unresponsive to conservative medical management since it was shown as a safe and effective alternative to hysterectomy.(2,3) Monopolar resectoscope necessitates an irrigating fluid that should be a non-conductive and salt free solution such as glycine 1.5% or sorbitol 3%.(4) Physiologic irrigating fluids (e.g. saline 0.9%) are contraindicated with these instruments since electric current generated by any monopolar electro surgical unit is preferentially conducted through low impedance fluid rather than through tissue and consequently it's difficult to initiate cutting and impossible to create significant tissue coagulation with these devices The clinical drawback of non-conductive irrigating solution (e.g. glycine 1.5%) is the risk of excessive fluid absorption leading to symptomatic dilutional hyponatremia and for hypotonic solutions, hypo-osmolarity and secondary cerebral oedema as Glycine is metabolized to carbon dioxide, water and ammonia, and may lead to intra-cellular over hydration and neurotoxicity which is clinically reflected as hypoxemia, agitation, nausea and hypertension.(5).Although rare, irreversible neurologic damage and death have been reported after excessive absorption of salt free irrigating solutions during routine operative hysteroscopy(6)Theoretically, distension with 0.9% saline as a distension medium avoids most of the above mentioned risks associated with hyper absorption of non electrolytic distension media(7) However, there is no doubt that excessive absorption of normal saline can be fatal(8).
Recently , it has been suggested that the type of anesthesia could modify fluid absorption(9). General anaesthesia has been associated with less Glycine absorption than epidural anaesthesia: the latter being associated with systemic vasodilatation(9).
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Assiut, Egypt
- Assiut University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- In this study we will include 60 patients (age ranged from 20 to 40 years) with uterine size less than 12 weeks and cavity depth less than 12cm. Different types of intrauterine lesions (submucous fibroids of types 0, 1 and 2 with diameter less than 4 cm, polyps,septum and adhesions).
Exclusion Criteria:
- Any case with the following diseases will be excluded from the study.
- Cardiac diseases (myocardial ischemia, myocardial infarction or valve lesions).
- Renal impairment.
- Neurological affection.
- Chest diseases.
- Hepatic impairment.
- coagulation abnormalities.
- Patient refusal.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: normal saline0.9%
0.9% saline distension media is used as long as diathermy is not in use
|
0.9% saline as distension medium as long as diathermy is not in use
|
|
Placebo Comparator: 1.5% GLYCINE
1.5% GLYCINE DURING OPERATIVE HYSTEROSCOPY as long as diathermy is in use
|
1.5% Glycine alone during hysteroscopy as long as diathermy is in use
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline Systolic Blood Pressure
Time Frame: data will be collected over 24 hours from the beginning of the procedure
|
Non-invasive blood pressure measurement by using sphygmomanometer cuff
|
data will be collected over 24 hours from the beginning of the procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: AHMED sonbaty, doctor, Assiut University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ahmed 2017
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on Normal Saline 0.9% Infusion Solution Bag
-
Sunnybrook Health Sciences CentreCompleted
-
Vanderbilt University Medical CenterCompleted
-
University of AlbertaWithdrawnPostural Orthostatic Tachycardia Syndrome
-
Nicholas M MohrCompletedEmergencies | Fluid Loss | Symptom Complex, TripleUnited States
-
University of South FloridaNot yet recruitingPost-ERCP Acute Pancreatitis
-
John W. Reeves, MDWhite Clover Research Foundation; White Clover Wellness and Research CenterSuspended
-
Royal Centre for Defence MedicineUniversity of OxfordCompletedIron-deficiency | Pulmonary Vascular Resistance Abnormality | Ventricular Function | Altitude Hypoxia
-
Taipei Veterans General Hospital, TaiwanUnknown
-
Anahita Rabiee MD MHSGrifols Shared Services North America IncRecruitingCirrhosis | Ascites HepaticUnited States
-
Medical University of South CarolinaTerminated